SureTrader Nadex Advertisement Interactive Brokers Advertisement SureTrader
Home > Boards > US OTC > Cannabis >

Cannabix Technologies Inc. (BLOZF)

Add BLOZF Price Alert      Hide Sticky   Hide Intro
Moderator: shell3, smoki, ILuvblo2, FreezeThese
Search This Board: 
Last Post: 5/19/2017 9:30:06 PM - Followers: 214 - Board type: Free - Posts Today: 0

Cannabix Technologies Inc.

(formerly West Point Resources Inc.)

Frankfurt: 8CT:FRA)

And is a Vancouver, B.C. based  company

Cannabix Technologies Inc. has
the exclusive North American license for
the Cannabix Marijuana Breathalyzer
from Cannabix Breathalyzer Inc.

Cannabix Technologies Inc. has
Worldwide Rights to
Partial ovoidal FAIMS electrode"
Patent 8,237,118
from the University of Florida



Rights for 10 Years after 1st Product sold

What is FAIMS-MS?

It Blocks Out Unwanted Molecules
 Letting only THC Molecules Threw the Electrode
40 Minute Video with Dr Yost

Cannabix Technologies' Inc. common shares trade on
the Canadian Securities Exchange
and US OTC Pinksheets and European Frankfurt Exchange.

US Patent Application

Canada Patent Application

Cannabix Technologies Inc. is the developer of the patent pending Cannabix Marijuana Breathalyzer for law enforcement and the workplace. The Cannabix Marijuana Breathalyzer drug-impairment recognition system is based on breath testing technology that has been developed to test individuals for recent consumption of the THC component of marijuana.  Cannabix is advancing its products to enable law enforcement personnel to use this technology to enhance detection of marijuana impaired driving offences on North American roads at a time when marijuana is becoming legal in many jurisdictions.  Cannabix is working to develop a drug-testing device that will detect Tetrahydrocannabinol (THC- the psychoactive component of marijuana that causes intoxication) using breath samples. The device would be used to provide detection of THC at the roadside to identify drivers intoxicated by the use of marijuana. The device will also be useful for other practical applications such as testing employees in the workplace where intoxication by THC can be hazardous.
The device is currently in BETA 1.0 development and the Company is rapidly developing this technology for BETA 2.0 for Third Party Testing

CSE:BLO          Pinksheets: BLOZF  Frankfurt: 8CT:FRA

Common Shares
Issued and Outstanding 

 (as of Janurary 31, 2016)
Warrants Issued but not Exercised  5,634,325
Options Issued but not Exercised  8,961,300
IF a Patent is Issued another 5M Shares

Fully Diluted w/Warrants, w/Options  and w/Patent 5M Shares IF ISSUED 
TOTAL DILUTED 105,690,101

Cannabix Corporate Video

Kal Malhi, President and Director
Kal Malhi, President, Director Mr. Malhi is a Vancouver based entrepreneur and the founder of Cannabix Breathalyzer Inc.  Mr. Malhi is a retired member of the Royal Canadian Mounted Police and is also President of BullRun Group, a private investment company specializing in early stage business development.  Mr Malhi brings a wealth of business and law enforcement experience to the management team and is cognizant of the issues of protecting individuals’ rights to privacy while maximizing public safety through law enforcement initiatives.

Dr. Raj Attariwala, MD, PhD.,  Lead Engineer
Dr. Attariwala is a Vancouver based dual board certified Radiologist and Nuclear Medicine physician certified in both Canada and the United States. He received his formal medical training at University of British Columbia with periods of specialized medical training at Memorial Sloan Kettering Cancer Centre (New York), UCLA and USC. He holds a doctorate in Biomedical Engineering from Northwestern University (Evanston, IL).  Dr.  Attariwala is a practicing physician in British Columbia and is the owner of AIM medical imaging in Vancouver.  He has pioneered advances in the field of whole body medical imaging thru his work and authored numerous publications and presented at international medical conferences on whole body imaging and cancer detection. Dr Attariwala has worked closely with the breath testing technology developed by the Karolinska Institute and Dr Olof Beck and utilized his educational training and background in Biomedical Engineering to formulate product design and patent applications for Cannabix Breathalyzer products.  Dr.  Attariwala also has several other medical device patents under developments in the field of Nuclear Medicine.

Dr. Bruce Goldberger, PhD,  Senior Advisor
Dr. Goldberger is a professor, and the director of toxicology for the Department of Pathology, Immunology and Laboratory Medicine in the College of Medicine at the University of Florida.  Dr. Goldberger is the editor-in-chief of the Journal of Analytical Toxicology; the president of the American Board of Forensic.

Richard A. Yost Ph.D., Scientific Advisor

Dr. Yost, Col. Allen R. & Margaret G. Crow Professor and Head of Analytical Chemistry at the University of Florida received his B.S. degree in Chemistry from the University of Arizona in 1974. In 1975 he pursued an NSF graduate fellowship at Michigan State University focusing on electronics and computerized instrumentation. He received his Ph.D. in 1979 and assumed the position of Assistant Professor at the University of Florida and went on to become head of the Analytical Chemistry Division.

Jared Boock Ph.D, Principal investigator
Worked on a high-field asymmetric waveform ion mobility spectrometry (FAIMS) - based
method of detection for transition metals. Conducted characterization of the types of ions that form
during the electrospray ionization (ESI) process for over 25 metal salts. Invented an atmospheric
pressure ion guide (patent pending). Taught four semesters of analytical chemistry laboratory; recipient of the Department of Chemistry Teaching Award for 2015.

Rocco Iannapollo, Advisor
Mr. Iannapollo is an expert on substance abuse programs with more than 20 years of experience in the oil and gas industry, working for fortune 50 companies. Rocco has extensive experience with supplier, employer, and DOT compliance policies and strategies. He also brings deep business acumen regarding operations and supply chain best practices. Mr. Iannapollo is a member of the Substance Abuse Program Administrator’s Association (SAPAA), the Drug and Alcohol Testing Industry Association (DATIA), as well as a speaker and regular contributor to the International Forum for Drug and Alcohol Testing (IFDAT).

Rav Mlait, MBA – CEO, Director
.Mr. Mlait has extensive experience in managing and raising capital for public and private companies. Mr. Mlait holds an MBA from Royal Roads University in British Columbia with a specialization in Executive Management and his BA (Economics) from Simon Fraser University and has worked with public companies listed on the TSX and TSX Venture exchange. Mr. Mlait was VP of Corporate development for knowledge-management and CRM software developer, Knexa Solutions Ltd., and financial web portal, Stockhouse Media Corporation.

Bryan Loree BA, CMA –CFO, Director
Mr. Loree has held various senior accounting roles for public and private companies in various industries including, renewable energy, exploration, and construction. During this time he has also performed capital raising activities for both private and public companies, primarily in the exploration and renewable energy sectors. Prior to entering the accounting field, Mr. Loree spent three years as an investor relations manager for public exploration companies and two years in the banking industry. Mr. Loree holds a Certified Management Accountant designation, a Financial Management Diploma from the British Columbia Institute of Technology, and a BA from Simon Fraser University.

Thomas Clarke, M,Sc, Director
Mr. Clarke served as a geologist for TSX Venture listed, BonTerra Resources from May 2010 to October, 2012. During his tenure, BonTerra defined an initial NI 43-101 compliant resource under his leadership. Thomas is a geologist holding a BSc. (Honours) and MSc in Geology from the University of the Witwatersrand as well as a BSc in Geography from the University of Lethbridge. 

Andrew Davies,  Advisor
Mr. Davies is a cannabinoid expert who has over 25 years of experience in the pharmaceutical industry and was instrumental in securing the first US IND for synthetic Cannabidiol (CBD) at Yale University. Andrew is a Chartered Mechanical Engineer and holds a BEng from the University of Liverpool and an International Executive MBA from the University of Middlesex Business School, London. Andrew is the CEO of STI Pharmaceuticals Ltd., a leading cannabinoid research company based in London, England. He is also a sought after speaker at cannabinoid conferences globally.

Dr. (h.c.) Marilyn Huestis, PhD, Scientific Advisor
Dr. Huestis is one of the world’s foremost experts on the effects of marijuana use on driving impairment. Dr. Huestis is a sought after international speaker, scholar and scientist. Dr. Huestis was a tenured Senior Investigator and Chief of Chemistry and Drug Metabolism at National Institute for Drug Abuse (NIDA’s) Intramural Research Program (IRP) in Baltimore, Maryland and a Professor at the University of Maryland School of Medicine (retired in 2016).  Dr. Huestis received her Bachelor’s degree (cum laude) in Biochemistry from Mount Holyoke College, a Master's in Clinical Chemistry with honors from the University of New Mexico, and a Ph.D. in Toxicology with honors from the University of Maryland School of Medicine. 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
BLOZF News: Live Testing with Cannabix Marijuana Breathalyzer Shows Excellent Sensitivity for THC and Related Metabolites 03/27/2017 08:30:00 AM
BLOZF News: Cannabix Technologies Provides Update on Marijuana Breathalyzer Development 02/16/2017 08:30:00 AM
BLOZF News: Cannabix Technologies Applauds Canadian Task Force Report on Cannabis Legalization and its Focus on Marijuana Impaired Driving 12/14/2016 09:00:00 AM
#18146  Sticky Note Number of Outstanding: 86,426,653 common shares shell3 05/05/17 03:01:48 PM
#18264   Found this quote interesting talking about Breath shell3 05/19/17 09:30:06 PM
#18263   Not sure, started last week for BTHCF and shell3 05/19/17 02:55:42 PM
#18262   This may be a noob question, but, what majorkaos 05/19/17 02:30:20 PM
#18261   Never been a "Penny Flipper" till 420, this PirateGary 05/19/17 01:35:55 PM
#18260   Indeed...Shhhhh RolandDoe 05/19/17 08:12:50 AM
#18259   Very quiet. EOM. TonyJoe1957 05/19/17 08:03:43 AM
#18258   You are my hero! dilligence 05/18/17 12:08:37 AM
#18257   I agree 100%. This is not the terrain AMG 05/17/17 11:48:13 PM
#18256   This stock is going to back to exactly dilligence 05/17/17 11:29:44 PM
#18255   Well looks like my fart was right...and I'll RolandDoe 05/17/17 12:30:19 PM
#18254   im not even in. hoyowasobo 05/17/17 10:07:36 AM
#18253   yes both sides. hoyowasobo 05/17/17 10:05:54 AM
#18252   Yeah Hoyo.. you should sell now and get Carthnel 05/17/17 09:23:32 AM
#18251   Yesturday was more of the MJ Sector Bounce shell3 05/17/17 09:18:48 AM
#18250   I'll bet that we see .60 us side RolandDoe 05/17/17 09:15:25 AM
#18249   On both the Canadian side and US side? RolandDoe 05/17/17 09:04:35 AM
#18248   yesterday was just a simple bounce off of hoyowasobo 05/17/17 08:59:25 AM
#18247   Thanks for the connection!! Kurtz75 05/16/17 06:15:06 PM
#18246   Some posts don't deserve a response...unfortunately though I AMG 05/16/17 06:12:16 PM
#18245   Funding This work was supported by the Southeast Center shell3 05/16/17 05:03:34 PM
#18244   *plug RolandDoe 05/16/17 04:26:04 PM
#18243   I don't think they are involved with Blozf RolandDoe 05/16/17 04:25:46 PM
#18242   Hi. Kurtz75 05/16/17 04:21:45 PM
#18241   Scientific/Technology GIANT recognizes the same thing us longs euroconversions 05/16/17 01:52:55 PM
#18240   I view it as nothing less than a AMG 05/16/17 01:15:56 PM
#18239   Interesting candle. Watching. $BLOZF jjr04001 05/16/17 12:41:19 PM
#18238   Great DD indeed What do you guys make of JBowsNose 05/16/17 12:27:03 PM
#18237   Looks like it's on....Like Donkey Kong.........get them while RolandDoe 05/16/17 11:48:30 AM
#18236   More investors are figuring your BLOZF is in JBowsNose 05/16/17 11:16:52 AM
#18235   200k vol that candle ... don't see a headline? FreezeThese 05/16/17 11:11:55 AM
#18234   Everytime I pop in here, it's like deja vu. Johnnnnnnnn 05/16/17 10:39:58 AM
#18233   Rav  Mlait,  CEO  commented, “This testing  marks  a  euroconversions 05/16/17 09:15:35 AM
#18232   Dr. Raj  Attariwala,  commented, “The  high resolving  power  euroconversions 05/16/17 09:14:44 AM
#18231   "When Cannabix first approached our lab with the euroconversions 05/16/17 09:13:23 AM
#18230   It amazes me how some simple minded individuals euroconversions 05/16/17 09:12:40 AM
#18229   this is cute.... but kal owns majority of namah sivaya 05/16/17 08:01:45 AM
#18228   I would like that for a press release. Carthnel 05/16/17 08:00:31 AM
#18227   You're right it is time... HealthMngr 05/16/17 12:48:49 AM
#18226   Might be time SO75 05/15/17 03:16:44 PM
#18225   Excellent DD Shell 3. AMG 05/13/17 11:11:32 AM
#18224   Here's what was gave at PITTCON 2017 shell3 05/13/17 05:21:02 AM
#18223   If you read about the Preffered Swab, Dräger shell3 05/12/17 10:06:49 PM
#18222   Interesting. I was listening to the news about PickRick 05/12/17 09:59:02 PM
#18221   Varian OraLab® and Dräger Drug Test® shell3 05/12/17 09:51:51 PM
#18220   Which company has the THC cheek swab test? PickRick 05/12/17 02:10:28 PM
#18219   Implants needed. EOM. TonyJoe1957 05/12/17 11:15:47 AM
#18218   LOL - Now That's Funny! AMG 05/12/17 11:09:09 AM
#18217   Bull - Go read my posts and find shell3 05/12/17 09:41:45 AM
#18216   Dang missed it ... that was quick FreezeThese 05/12/17 09:32:44 AM
#18214   it you don't think it is significant, it namah sivaya 05/12/17 09:16:07 AM